UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (246) 246
Patent (139) 139
Book Chapter (3) 3
Newspaper Article (3) 3
Book / eBook (2) 2
Publication (2) 2
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (140) 140
life sciences & biomedicine (125) 125
humans (81) 81
female (64) 64
male (63) 63
electricity (56) 56
electric communication technique (55) 55
pictorial communication, e.g. television (55) 55
chemistry (53) 53
metallurgy (47) 47
middle aged (42) 42
life sciences (41) 41
transmission of digital information, e.g. telegraphiccommunication (40) 40
physics (39) 39
advertising (38) 38
cardiovascular system & cardiology (38) 38
coding or ciphering apparatus for cryptographic or otherpurposes involving the need for secrecy (38) 38
cryptography (38) 38
display (38) 38
education (38) 38
seals (38) 38
cardiac & cardiovascular systems (35) 35
performing operations (35) 35
transporting (35) 35
organic chemistry (34) 34
adult (33) 33
aged (33) 33
stents (31) 31
risk factors (28) 28
accessories, closures, or fittings therefor (25) 25
containers for storage or transport of articles or materials,e.g. bags, barrels, bottles, boxes, cans, cartons, crates,drums, jars, tanks, hoppers, forwarding containers (25) 25
conveying (25) 25
handling thin or filamentary material (25) 25
packages (25) 25
packaging elements (25) 25
packing (25) 25
storing (25) 25
acyclic or carbocyclic compounds (24) 24
treatment outcome (24) 24
prospective studies (23) 23
animals (22) 22
abridged index medicus (21) 21
calculating (20) 20
computing (20) 20
counting (20) 20
data processing systems or methods, specially adapted foradministrative, commercial, financial, managerial, supervisoryor forecasting purposes (20) 20
electric digital data processing (20) 20
information storage (20) 20
information storage based on relative movement between recordcarrier and transducer (20) 20
patients (20) 20
systems or methods specially adapted for administrative,commercial, financial, managerial, supervisory or forecastingpurposes, not otherwise provided for (20) 20
analysis (19) 19
compositions based thereon (19) 19
fuels (19) 19
gastroenterology & hepatology (19) 19
lubricants (19) 19
lubricating compositions (19) 19
macromolecular compounds obtained by reactions only involvingcarbon-to-carbon unsaturated bonds (19) 19
organic macromolecular compounds (19) 19
peat (19) 19
petroleum, gas or coke industries (19) 19
research (19) 19
technical gases containing carbon monoxide (19) 19
their preparation or chemical working-up (19) 19
use of chemical substances either alone or as lubricatingingredients in a lubricating composition (19) 19
broadcast communication (18) 18
stent (17) 17
time factors (17) 17
cardiology and cardiovascular medicine (16) 16
heterocyclic compounds (16) 16
inflammatory bowel disease (16) 16
thrombosis (15) 15
610 medicine & health (14) 14
cardiovascular (13) 13
rabbits (13) 13
young adult (13) 13
adolescent (12) 12
france (12) 12
aged, 80 and over (11) 11
clinic for gastroenterology and hepatology (11) 11
clinical trials (11) 11
follow-up studies (11) 11
heart attacks (11) 11
implants (11) 11
percutaneous coronary intervention (11) 11
physical sciences (11) 11
[sdv]life sciences [q-bio] (10) 10
animal and vegetable oils, fats, fatty substances and waxes (10) 10
biochemistry & molecular biology (10) 10
candles (10) 10
care and treatment (10) 10
chemical or physical processes, e.g. catalysis or colloidchemistry (10) 10
detergent compositions (10) 10
detergents (10) 10
fatty acids therefrom (10) 10
physical or chemical processes or apparatus in general (10) 10
recovery of glycerol (10) 10
recurrence (10) 10
resin soaps (10) 10
science & technology - other topics (10) 10
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (341) 341
French (85) 85
German (30) 30
Portuguese (9) 9
Spanish (5) 5
Chinese (4) 4
Norwegian (3) 3
Czech (2) 2
Indonesian (2) 2
Greek (1) 1
Hungarian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA : the journal of the American Medical Association, ISSN 0098-7484, 08/2017, Volume 318, Issue 6, pp. 557 - 566
IMPORTANCE: Bronchiolitis obliterans syndrome has been associated with increased morbidity and mortality after allogeneic hematopoietic stem cell transplant... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic Neoplasms - therapy | Recurrence | Double-Blind Method | Bronchiolitis Obliterans - etiology | Hematologic Neoplasms - mortality | Humans | Middle Aged | Male | Transplantation, Homologous | Bronchiolitis Obliterans - prevention & control | Anti-Bacterial Agents - therapeutic use | Azithromycin - adverse effects | Disease-Free Survival | Azithromycin - therapeutic use | Treatment Failure | Hematopoietic Stem Cell Transplantation - adverse effects | Intention to Treat Analysis | Adult | Female | Anti-Bacterial Agents - adverse effects | Respiratory Function Tests | Transplantation Conditioning | Complications and side effects | Usage | Patient outcomes | Analysis | Lung diseases | Azithromycin | Stem cells | Dosage and administration | Transplantation | Pulmonary ventilation | Drug therapy | Risk factors | Respiratory function | Cell survival | Hematology | Transplants & implants | Syngeneic grafts | Bronchopneumonia | Mortality | Lung transplantation | Clinical trials | Stem cell transplantation | Malignancy | Patients | Survival | Morbidity | Hemopoiesis | Incidence | Air flow | Motivation | Respiratory diseases | Pulmonary functions | Bronchiolitis obliterans | Index Medicus | Abridged Index Medicus | Original Investigation | Research
Journal Article
Journal Article
by Vranckx, Pascal and Valgimigli, Marco and Jüni, Peter and Hamm, Christian and Steg, Philippe Gabriel and Heg, Dik and van Es, Gerrit Anne and McFadden, Eugene P and Onuma, Yoshinobu and van Meijeren, Cokky and Chichareon, Ply and Benit, Edouard and Möllmann, Helge and Janssens, Luc and Ferrario, Maurizio and Moschovitis, Aris and Zurakowski, Aleksander and Dominici, Marcello and Van Geuns, Robert Jan and Huber, Kurt and Slagboom, Ton and Serruys, Patrick W and Windecker, Stephan and Abdellaoui, Mohamed and Adlam, David and Akin, Ibrahim and Albarran Gonzalez-Trevilla, Agustin and Almeida, Manuel and Alves Lemos Neto, Pedro and Aminian, Adel and Anderson, Richard and Andreae, Rick and Angioi, Michael and Asano, Taku and Barbato, Emanuele and Barlis, Peter and Barraud, Pascal and Bertrand, Olivier and Beygui, Farzin and Bolognese, Leonardo and Botelho, Roberto and Bouwman, Coby and Bressers, Marco and Brunel, Philippe and Buszman, Pawel and Buysschaert, Ian and Canas da Silva, Pedro and Carrie, Didier and Cequier, Angel and Chin Chang, Chun and Chowdhary, Saqib and Collet, Carlos and Colombo, Antonio and Cotton, James and Cruz Ferreira, Rui and Curello, Salvatore and Curzen, Nick and de Bot, Judith and de Vreede, Tone and Delle Karth, Georg and Dijksma, Lynn and Édes, István and Eeckhout, Eric and Eitel, Ingo and Faluközy, József and Fath-Ordoubadi, Farzin and Fontos, Geza and Francisco Diaz, Jose and Freitas Quintella, Edgard and Frey, Bernhard and Friedrich, Guy and Galasko, Gavin and Galuszka, Grzegorz and Gama Ribeiro, Vasco and Garg, Scot and Gargiulo, Giuseppe and Geisler, Tobias and Gelev, Valeri and Ghandilyan, Art and Goicolea, Javier and Gori, Tommaso and Gragnano, Felice and Guimarães, Ana and Haude, Michael and Heijke, Pieter and Hernández Antolin, Rosa Ana and Hildick-Smith, David and Hillen, Dorien and Hoekman, Ina and Hofma, Sjoerd and Holmvang, Lene and Hoole, Stephen and Horváth, Iván and Hugense, Annemarie and Ibrahim, Karim and Iñiguez, Andres and Isaaz, Karl and Jambrik, Zoltán and Jasionowicz, Pawel and Jonk, Judith and ... and GLOBAL LEADERS Investigators
The Lancet (British edition), ISSN 0140-6736, 09/2018, Volume 392, Issue 10151, pp. 940 - 949
We hypothesised that ticagrelor, in combination with aspirin for 1 month, followed by ticagrelor alone, improves outcomes after percutaneous coronary... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Myocardial Infarction - mortality | Purinergic P2Y Receptor Antagonists - administration & dosage | Humans | Middle Aged | Male | Coronary Artery Disease - drug therapy | Coronary Artery Disease - mortality | Adenosine - administration & dosage | Ticlopidine - analogs & derivatives | Aspirin - administration & dosage | Drug-Eluting Stents - adverse effects | Coronary Angiography | Adenosine - analogs & derivatives | Platelet Aggregation Inhibitors - administration & dosage | Intention to Treat Analysis | Ticlopidine - administration & dosage | Clopidogrel | Female | Aged | Myocardial Infarction - prevention & control | Drug Therapy, Combination | Ticagrelor | Percutaneous Coronary Intervention | Aggregation | Blood platelets | Analysis | Myocardial infarction | Intervention | Therapy | Surgical implants | Heart attacks | Disorders | Cardiovascular disease | Drug delivery | Evidence-based medicine | Bleeding | Subgroups | Consortia | Randomization | Motivation | Implants | Heart diseases | Stents | Drug dosages | Aspirin | Stroke | Mortality | Coronary artery | Implantation | Coronary artery disease | Patients | Coronary vessels | Fatalities | Infarction | Acute coronary syndromes | Biosensors | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2015, Volume 65, Issue 8, pp. 777 - 786
Background The currently recommended duration of dual antiplatelet therapy (DAPT) in drug-eluting stent (DES) recipients is 12 months to reduce the risk of... 
double antiplatelet duration | percutaneous coronary angioplasty | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Postoperative Complications - prevention & control | Male | Hemorrhage - prevention & control | Aspirin - administration & dosage | Drug-Eluting Stents - adverse effects | Middle East | Early Termination of Clinical Trials | Coronary Restenosis - diagnosis | Coronary Artery Disease - physiopathology | Time Factors | Aspirin - adverse effects | Percutaneous Coronary Intervention - methods | Hemorrhage - etiology | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Everolimus | Coronary Restenosis - etiology | Platelet Aggregation Inhibitors - adverse effects | Coronary Vessels - pathology | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Europe | Coronary Restenosis - prevention & control | Treatment Outcome | Coronary Artery Disease - mortality | Postoperative Complications - diagnosis | Ticlopidine - analogs & derivatives | Coronary Artery Disease - therapy | Coronary Artery Disease - diagnosis | Coronary Vessels - surgery | Aged | Percutaneous Coronary Intervention - adverse effects | Aspirin | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
The Lancet (British edition), ISSN 0140-6736, 09/2018, Volume 392, Issue 10153, pp. 1117 - 1126
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2014, Volume 64, Issue 11, pp. B131 - B131
Background The CeloNova COBRA PzF(TM) Coronary Stent is a new stent design, balloon expandable cobalt chromium alloy coronary stent that is pre-mounted on a... 
Cardiovascular | Internal Medicine | Stents | Blood clots
Journal Article